long intergenic non-protein coding RNA 2147Genealiases: []
Q-omics provides the consensus-scored LINC02147 profile across patient tissues and cancer cell-line models. LINC02147 expression is associated with patient survival in 24 of 34 cancer types, with the highest sampling consensus in HNSC. Among the 18 cancer types available for tumor–normal comparison, LINC02147 is differentially expressed in 14, with the highest sampling consensus in KIRP. Additionally, LINC02147 RNA expression shows 8,484 significant gene co-expression associations, with the highest sampling consensus in PAAD. Together, these results highlight HNSC, KIRP, and PAAD as cancer lineages where LINC02147 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02147 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02147 survival associations across molecular data types. LINC02147 RNA expression shows survival associations in the most cancer types (24). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02147 RNA expression–survival associations across cancer types. High LINC02147 expression shows unfavorable associations in LUSC, LGG and SKCM, but favorable associations in HNSC, LUAD and MESO. The HNSC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify HNSC as the clearest survival context for LINC02147 RNA expression.
This table summarizes LINC02147 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 14. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02147. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02147 shows lower tumor expression in KIRP, HNSC, KIRC, COAD, KICH and THCA. The KIRP box plot shows higher LINC02147 RNA expression in normal versus tumor tissue (log2 FC = −0.717, t-test p < 0.001).
This table shows molecular features associated with LINC02147 in patient tissues and cancer cell lines. In patient samples, LINC02147 shows the broadest associations at the RNA and protein expression levels, with PAAD recurring as the lineage with the largest associated feature set.
